Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition: Tuberculosis Interventions: Biological: MTBVAC; Biological: BCG Sponsors: Biofabri, S.L; TuBerculosis Vaccine Initiative; University of Cape Town; Institut Pasteur de Madagascar; Biomedical Research Center EPLS; Universidad de Zaragoza; University of Stellenbosch; University of KwaZulu; Wits Health Consortium (Pty) Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials